Results 21 to 30 of about 30,919 (277)

Glycosuria and Renal Outcomes in Patients with Nondiabetic Advanced Chronic Kidney Disease [PDF]

Scientific Reports, 2016
Sodium glucose cotransporter 2 inhibitors have shown a potential for renoprotection beyond blood glucose lowering. Glycosuria in nondiabetic patients with chronic kidney disease (CKD) is sometimes noted.
Chi‐Chih Hung, Hugo You‐Hsien Lin, Jia‐Jung Lee, Lee‐Moay Lim, Yi‐Wen Chiu, Heng-Pin Chiang, Shang‐Jyh Hwang, Hung‐Chun Chen   +7 more
openalex   +2 more sources

Slowly Progressive Type 1 Diabetes following Steroid-Sensitive Relapsing Nephrotic Syndrome in Childhood: A Case Report [PDF]

Biomedicine Hub
Introduction: In rare cases, idiopathic nephrotic syndrome (NS) and type 1 diabetes coexist, with diabetes typically preceding NS or presenting almost simultaneously with an acute onset requiring immediate insulin therapy.
Masashi Kitahara, Kenji Kurata
doaj   +2 more sources

Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition [PDF]

Kidney International Reports
Greco B. Malijan, Daniel Chapman, Stewart Moffat, Rebecca J. Sardell, Natalie Staplin, Martin J. Landray, Colin Baigent, Michael G. Shlipak, Richard Haynes, Joachim H. Ix, Michael Hill, William G. Herrington, Parminder K. Judge   +12 more
doaj   +2 more sources

Albuminuria and Glycosuria [PDF]

Postgraduate Medical Journal, 1928
Adolphe Abrahams
openaire   +4 more sources

Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis [PDF]

Endocrinology and Metabolism, 2023
When sodium-glucose cotransporter-2 (SGLT2) inhibitors were first introduced a decade ago, no one expected them to have substantial effects beyond their known glucose-lowering effects, until the emergence of evidence of their robust renal and ...
Eun Sil Koh, Gheun-Ho Kim, Sungjin Chung
doaj   +1 more source

Preterm Glycosuria – New Data from a Continuous Glucose Monitoring System

Neonatology, 2018
Mateusz Jagła, Izabela Szymońska, Katarzyna Starzec, Przemko Kwinta   +3 more
openalex   +3 more sources

Bittersweet: infective complications of drug-induced glycosuria in patients with diabetes mellitus on SGLT2-inhibitors: two case reports

BMC Infectious Diseases, 2021
Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors are novel hypoglycemic agents which reduce reabsorption of glucose at the renal proximal tubule, resulting in significant glycosuria and increased risk of genital mycotic infections (GMI ...
C. Bartolo, V. Hall, N. Friedman, C. Lanyon, A. Fuller, C. Morrissey, E. Athan   +6 more
semanticscholar   +1 more source

Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea [PDF]

Endocrinology and Metabolism, 2020
Background We assessed the glucose-lowering efficacy of adding empagliflozin versus dose escalating existing medications in patients with uncontrolled type 2 diabetes (T2D).
Yujin Shin, Ji Hye Moon, Ho Jun Chin, Ele Ferrannini, Soo Lim   +4 more
doaj   +1 more source

SGLT2-inhibitors; more than just glycosuria and diuresis

Heart Failure Reviews, 2020
Heart failure (HF) continues to be a serious public health challenge despite significant advancements in therapeutics and is often complicated by multiple other comorbidities.
Amir Fathi, K. Vickneson, Jagdeep S. Singh   +2 more
semanticscholar   +1 more source

Outcome of Acquired Fanconi Syndrome Associated with Ingestion of Jerky Treats in 30 Dogs

Animals, 2022
Acquired canine proximal renal tubulopathy (Fanconi syndrome) related to excessive ingestion of jerky treats has been recognized since 2007. This study aimed to improve knowledge about the syndrome’s characteristics, especially long-term outcome.
Stinna Nybroe, Charlotte R. Bjørnvad, Camilla F. H. Hansen, Tenna S. L. Andersen, Ida N. Kieler   +4 more
doaj   +1 more source